NO20004903L - C11 oksymyl og hydroksylaminoprostaglandiner anvendbare som FP-agonister - Google Patents

C11 oksymyl og hydroksylaminoprostaglandiner anvendbare som FP-agonister

Info

Publication number
NO20004903L
NO20004903L NO20004903A NO20004903A NO20004903L NO 20004903 L NO20004903 L NO 20004903L NO 20004903 A NO20004903 A NO 20004903A NO 20004903 A NO20004903 A NO 20004903A NO 20004903 L NO20004903 L NO 20004903L
Authority
NO
Norway
Prior art keywords
hydroxylaminoprostaglandins
oxymyl
agonists
useful
hydroxylaminoprostaglandins useful
Prior art date
Application number
NO20004903A
Other languages
English (en)
Other versions
NO20004903D0 (no
Inventor
Mitchell Anthony Delong
Jr Jack Snyder Amburgey
John August Wos
Biswanath De
David Lindsey Soper
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20004903D0 publication Critical patent/NO20004903D0/no
Publication of NO20004903L publication Critical patent/NO20004903L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20004903A 1998-03-31 2000-09-29 C11 oksymyl og hydroksylaminoprostaglandiner anvendbare som FP-agonister NO20004903L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8021698P 1998-03-31 1998-03-31
PCT/IB1999/000480 WO1999050242A1 (en) 1998-03-31 1999-03-22 C11 oxymyl and hydroxylamino prostaglandins useful as fp agonists

Publications (2)

Publication Number Publication Date
NO20004903D0 NO20004903D0 (no) 2000-09-29
NO20004903L true NO20004903L (no) 2000-11-29

Family

ID=22155990

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004903A NO20004903L (no) 1998-03-31 2000-09-29 C11 oksymyl og hydroksylaminoprostaglandiner anvendbare som FP-agonister

Country Status (21)

Country Link
EP (1) EP1066254B1 (no)
JP (1) JP2002509916A (no)
KR (1) KR20010042285A (no)
CN (1) CN1295559A (no)
AR (1) AR018590A1 (no)
AT (1) ATE296284T1 (no)
AU (1) AU749540B2 (no)
BR (1) BR9909268A (no)
CA (1) CA2324590C (no)
DE (1) DE69925475T2 (no)
ES (1) ES2244208T3 (no)
HU (1) HUP0103403A3 (no)
IL (1) IL138447A0 (no)
NO (1) NO20004903L (no)
NZ (1) NZ506855A (no)
PE (1) PE20000351A1 (no)
PL (1) PL343125A1 (no)
SK (1) SK14722000A3 (no)
TR (1) TR200002795T2 (no)
WO (1) WO1999050242A1 (no)
ZA (1) ZA992394B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000051980A1 (en) 1999-03-05 2000-09-08 The Procter & Gamble Company C16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
KR100437873B1 (ko) * 2001-05-08 2004-06-26 연성정밀화학(주) 프로스타글란딘 유도체의 제조방법 및 그의 입체특이적출발물질
WO2006047466A2 (en) 2004-10-21 2006-05-04 Duke University Ophthamological drugs
CN101535239A (zh) * 2006-11-09 2009-09-16 博士伦公司 某些取代的醇的选择的立体异构体的合成
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
CN102101835B (zh) * 2009-12-16 2015-07-22 武汉启瑞药业有限公司 前列腺素衍生物及其中间体的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538120A (en) * 1967-05-22 1970-11-03 Ciba Geigy Corp Cyclopentyl-alkanoic acids
US3798275A (en) * 1972-04-05 1974-03-19 Ciba Geigy Corp Etherified mercapto-methoxyamines

Also Published As

Publication number Publication date
AR018590A1 (es) 2001-11-28
JP2002509916A (ja) 2002-04-02
AU3270299A (en) 1999-10-18
BR9909268A (pt) 2001-09-04
DE69925475D1 (de) 2005-06-30
PL343125A1 (en) 2001-07-30
HUP0103403A2 (hu) 2002-01-28
CN1295559A (zh) 2001-05-16
IL138447A0 (en) 2001-10-31
DE69925475T2 (de) 2005-11-17
ES2244208T3 (es) 2005-12-01
CA2324590A1 (en) 1999-10-07
AU749540B2 (en) 2002-06-27
NO20004903D0 (no) 2000-09-29
TR200002795T2 (tr) 2001-01-22
EP1066254B1 (en) 2005-05-25
SK14722000A3 (sk) 2001-07-10
ATE296284T1 (de) 2005-06-15
ZA992394B (en) 1999-09-30
KR20010042285A (ko) 2001-05-25
PE20000351A1 (es) 2000-06-22
HUP0103403A3 (en) 2002-12-28
CA2324590C (en) 2006-06-13
EP1066254A1 (en) 2001-01-10
NZ506855A (en) 2003-02-28
WO1999050242A1 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
NO20032753D0 (no) Forbindelse og anvendelse derav
DK1131301T3 (da) 2-phenylbenzimidazoler og 2-phenylindoler, fremstilling af anvendelse heraf
FI981614A0 (fi) Laakerin kunnon evakuointi
DK1070058T3 (da) (4-Arylsulfonylamino)-tetrahydropyran-4-carboxylsyrehydroxamider
DE59913976D1 (de) Elektromagnet
NO990511D0 (no) Sidebr°nn-tilkopling
NO992198D0 (no) R°rledningspigg
DK1012137T3 (da) Aromatiske C-16-C-20-substituerede tetrahydro-prostaglandiner og deres anvendelse som prostaglandin FP-agonister
NO20006488D0 (no) Sammensetning og anvendelse
IS5827A (is) Múskarín gerandefni og mótlyf
NO995513D0 (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-A agonister
NO20013237L (no) 3,3-biarylpiperidin og 2,2-biarylmorfolinderivater
NO20010660D0 (no) Isolator
NO20004903L (no) C11 oksymyl og hydroksylaminoprostaglandiner anvendbare som FP-agonister
DE69917156D1 (de) Pufferdichtung
DE69927913D1 (de) Verdichter
NO20004904D0 (no) C11 oksymyl og hydroksylaminoprostaglandiner anvendbare som medikamenter
MA26666A1 (fr) Antioxide, composition antiproliferee, y compris carnitine et carotenoide.
FI104197B1 (fi) Nurkkaliitos
DE69840421D1 (de) Teilnehmerkontextes
IS5799A (is) FKBP latar
IT245859Y1 (it) Compressore.
BR9707943B (pt) Composto, e, glutarimida
DE59909590D1 (de) Azidfreie, gaserzeugende zusammensetzung
NO990512D0 (no) Sidebr°nn-tilkopling

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application